How the gut microbiome may influence chemotherapy response in urothelial carcinoma
Cancer Research Communications shared a post on X about a recent paper by Laura Bukavina et al. titled “Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation” published in AACR Journals.
Authors: Laura Bukavina, Rashida Ginwala, Mohamed Eltoukhi, Mohit Sindhani, Megan Prunty, Daniel Geynisman, Pooja Ghatalia et al.
“Want to learn more about the gut microbiome in bladder cancer? This study provides important insights into how the gut microbiome may influence chemotherapy response in urothelial carcinoma.”
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared this post, adding:
“We are very excited to keep pushing the field of microbiome… now with prospective trials, intravesical therapy and FMT! More to come.”
Source: Cancer Research Communications/X and Laura Bukavina/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023